Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 250 points on Thursday
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday’s Mid-Day Session
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.
Forma Therapeutics Hldgs Q2 EPS $(1.10) Misses $(0.99) Estimate
Forma Therapeutics Hldgs (NASDAQ:FMTX) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(0.99) by 11.11 percent. This is a 19.57 percent decrease over losses of $(0.92) per
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell
• Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Earnings Outlook For Forma Therapeutics Hldgs
Forma Therapeutics Hldgs (NASDAQ:FMTX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement.
Analysts estimate that Forma Therapeutics Hldgs will report an earnings per share (EPS) of $-0.99.
Read Why Forma Therapeutics’ Current Price Level Is ‘Attractive Entry Point’
During the European Hematology Association (EHA) conference, Forma Therapeutics Holdings Inc (NASDAQ:FMTX) presented updated results from the 12-week open-label extension (OLE) of…
Forma Therapeutics Highlights Etavopivat Development Expansion and Introduces New Oncology Program from Research Pipeline at Inaugural Research and Development (R&D) Day
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers, will hold a virtual R&D Day today to provide a comprehensive update on its pipeline and strategic vision.
Earnings Scheduled For May 6, 2022
Companies Reporting Before The Bell
• Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
Preview: Forma Therapeutics Hldgs’s Earnings
Forma Therapeutics Hldgs (NASDAQ:FMTX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement.
Analysts estimate that Forma Therapeutics Hldgs will report an earnings per share (EPS) of $-1.05.